Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancerDong M Shin, Bonnie S Glisson, Fadlo R Khuri, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 12, 2019
GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusionWei Zhang, Taylor A Williams, Ankur S Bhagwath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2008
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II studyEzra E W Cohen, Lee S Rosen, Everett E Vokes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303Ann Marie Egloff, Ju-Whei Lee, Corey J Langer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2014
A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinomaC H Chung, J W Lee, R J Slebos, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2012
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neckJay S Cooper, Qiang Zhang, Thomas F Pajak, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2024
Treatment of the neck in residual/recurrent disease after chemoradiotherapy for advanced primary laryngeal cancerJuan P Rodrigo, Fernando López-Álvarez, Jesús E Medina, et al.
BMC Cancer|May 19, 2011
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology GroupHarry H Yoon, Paul J Catalano, Kathleen M Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931Z S Zumsteg, M Luu, C Fortpied, et al.
The New England Journal of Medicine|May 7, 2004
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neckJay S Cooper, Thomas F Pajak, Arlene A Forastiere, et al.
Pageof 18